231 related articles for article (PubMed ID: 29950532)
21. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory.
Ducos C; Rigo M; Larroumet A; Delyfer MN; Korobelnik JF; Monlun M; Foussard N; Poupon P; Haissaguerre M; Blanco L; Mohammedi K; Rigalleau V
Diabetes Metab; 2021 Feb; 47(1):101156. PubMed ID: 32387701
[TBL] [Abstract][Full Text] [Related]
22. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
Turk Z; Mesić R; Benko B
Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
[TBL] [Abstract][Full Text] [Related]
23. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.
Simó R; Lecube A; Sararols L; García-Arumí J; Segura RM; Casamitjana R; Hernández C
Diabetes Care; 2002 Dec; 25(12):2282-6. PubMed ID: 12453974
[TBL] [Abstract][Full Text] [Related]
24. Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control.
Al-Sowygh ZH; Ghani SMA; Sergis K; Vohra F; Akram Z
Clin Implant Dent Relat Res; 2018 Jun; 20(3):345-351. PubMed ID: 29350883
[TBL] [Abstract][Full Text] [Related]
25. Increased serum levels of advanced glycation end-products and diabetic complications.
Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
[TBL] [Abstract][Full Text] [Related]
26. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
[TBL] [Abstract][Full Text] [Related]
27. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.
Foo V; Quah J; Cheung G; Tan NC; Ma Zar KL; Chan CM; Lamoureux E; Tien Yin W; Tan G; Sabanayagam C
J Diabetes; 2017 Feb; 9(2):200-207. PubMed ID: 27043025
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
29. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
30. Significance of HbA1c levels in diabetic retinopathy extremes in South Africa.
Mjwara M; Khan M; Kruse CH; Sibanda W; Connolly C
S Afr Med J; 2021 Sep; 111(9):886-890. PubMed ID: 34949254
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
32. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
33. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy.
Choudhuri S; Dutta D; Chowdhury IH; Mitra B; Sen A; Mandal LK; Mukhopadhyay S; Bhattacharya B
Diabetes Res Clin Pract; 2013 Jun; 100(3):376-84. PubMed ID: 23602454
[TBL] [Abstract][Full Text] [Related]
34. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy.
Sebag J; Buckingham B; Charles MA; Reiser K
Arch Ophthalmol; 1992 Oct; 110(10):1472-6. PubMed ID: 1417549
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
[TBL] [Abstract][Full Text] [Related]
36. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes.
Hu J; Hsu H; Yuan X; Lou K; Hsue C; Miller JD; Lu J; Lee Y; Lou Q
J Endocrinol Invest; 2021 Jun; 44(6):1229-1236. PubMed ID: 32897535
[TBL] [Abstract][Full Text] [Related]
37. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
[TBL] [Abstract][Full Text] [Related]
38. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
Malik RA; Li C; Aziz W; Olson JA; Vohra A; McHardy KC; Forrester JV; Boulton AJ; Wilson PB; Liu D; McLeod D; Kumar S
J Cell Mol Med; 2005; 9(3):692-7. PubMed ID: 16202216
[TBL] [Abstract][Full Text] [Related]
39. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
[TBL] [Abstract][Full Text] [Related]
40. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]